Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birte-Swantje Schneevoigt

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Clinical Genitourinary Cancer|June 8, 2017
Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder CancerGerald B Schulz, Tobias Grimm, Alexander Buchner, et al.
Urologic Oncology|July 2, 2017
Follow-up of high-risk bladder cancer-Is it safe to perform fluorescence endoscopy multiple times in the same patient?Maria Apfelbeck, Tobias Grimm, Alexander Kretschmer, et al.
World Journal of Urology|December 25, 2016
Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complicationsAlexander Kretschmer, Tobias Grimm, Alexander Buchner, et al.
Scandinavian Journal of Urology|March 24, 2017
Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stageAlexander Buchner, Tobias Grimm, Birte-Swantje Schneevoigt, et al.
Histopathology|June 6, 2014
Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancerAnna Fischbach, Anja Rogler, Ramona Erber, et al.
The Journal of Urology|August 11, 2016
Prognostic Features for Objectively Defined Urinary Continence after Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary CohortAlexander Kretschmer, Tobias Grimm, Alexander Buchner, et al.
BJU International|June 25, 2020
Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trialGeorgios Gakis, Alexander Karl, Simone Bertz, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Clinical Genitourinary Cancer|June 8, 2017
Prognostic Value of the Preoperative Platelet-to-leukocyte Ratio for Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder CancerGerald B Schulz, Tobias Grimm, Alexander Buchner, et al.
Urologic Oncology|July 2, 2017
Follow-up of high-risk bladder cancer-Is it safe to perform fluorescence endoscopy multiple times in the same patient?Maria Apfelbeck, Tobias Grimm, Alexander Kretschmer, et al.
World Journal of Urology|December 25, 2016
Prospective evaluation of health-related quality of life after radical cystectomy: focus on peri- and postoperative complicationsAlexander Kretschmer, Tobias Grimm, Alexander Buchner, et al.
Scandinavian Journal of Urology|March 24, 2017
Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stageAlexander Buchner, Tobias Grimm, Birte-Swantje Schneevoigt, et al.
Histopathology|June 6, 2014
Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancerAnna Fischbach, Anja Rogler, Ramona Erber, et al.
The Journal of Urology|August 11, 2016
Prognostic Features for Objectively Defined Urinary Continence after Radical Cystectomy and Ileal Orthotopic Neobladder in a Contemporary CohortAlexander Kretschmer, Tobias Grimm, Alexander Buchner, et al.
BJU International|June 25, 2020
Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trialGeorgios Gakis, Alexander Karl, Simone Bertz, et al.
Pageof 1